Exhibition at ARABLAB 2023 in Dubai
SMEA members at Shimadzu booth
Shimadzu Middle East & Africa FZE (hereafter SMEA), a Shimadzu group company in UAE, showcased at ARABLAB 2023 held at Dubai World Trade Centre from 19th to 21st September, which is one of the biggest trade shows of the analytical industry in the Middle East and Africa area. It is a platform to connect with not only our customers from a wide range of industries, including medical, environmental, petrochemical, construction, forensics, agriculture, and manufacturing, but also our partners and suppliers. This year, Shimadzu featured a series of seminars on all three days in the areas of food, clinical, pharmaceutical, and environment.
Launch of Brevis GC-2050
Several instruments from key product categories were showcased at the Shimadzu booth, including LCMS-8060, Nexera series, LCMS-2050, IRXross, GCMS-TQ8050 NX, Gas Analyzer (Nexis GC-2030 with VUV Analytics LUMA), and AGS-X. SMEA team had an opportunity to explain their features and capabilities to customers. Also, our new product, Brevis GC-2050 was unveiled at the venue.
Our new product, Brevis GC-2050
Our new group company, Shimadzu Diagnostics Europe (located in France), and our partners Restek Corporation, Specac Ltd, and VUV Analytics Inc. joined us at our booth, appealing Shimadzu as a complete solution provider by displaying the accessories of our equipment.
Autograph AGS-X Series Table-TOP Precision Universal Tester was also showcased.
Shimadzu had one of the biggest booths at the show.
Two closed meeting rooms were prepared on the second floor of the Shimadzu booth for discussion with customers.
Comment from the Person in Charge
ARABLAB is an important exhibition for Shimadzu to connect with customers and increase brand awareness and visibility. Our booth design was well received by customers and partners. Most importantly, the Shimadzu team was able to have in-depth discussions with customers and industry experts about our latest technologies and how our solutions can improve the efficiency of their labs.